Vivasvan S. Vykunta

Vivasvan S. Vykunta

Auto-generated profile, based on publicly available information

Vivasvan S. Vykunta

Gladstone-UCSF Institute of Genomic Immunology, San Francisco, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2022 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
BSBrian R. Shy
Brian R. Shy
VVVivasvan S. Vykunta
Vivasvan S. Vykunta
AHAlvin Ha
Alvin Ha
ATAlexis Talbot
Alexis Talbot
TRTheodore L. Roth
Theodore L. Roth
AMAlex Marson
Alex Marson

25 April 2023 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
DFDana V. Foss
Dana V. Foss
JMJoseph J. Muldoon
Joseph J. Muldoon
DNDavid N. Nguyen
David N. Nguyen
DCDaniel Carr
Daniel Carr
SSSrishti U. Sahu
Srishti U. Sahu
RWRoss C. Wilson
Ross C. Wilson

9 November 2022 in Science Translational Medicine
Verified
Journal Article
Open access
DGDaniel B. Goodman
Daniel B. Goodman
CACamillia S. Azimi
Camillia S. Azimi
KKKendall Kearns
Kendall Kearns
ATAlexis Talbot
Alexis Talbot
KGKiavash Garakani
Kiavash Garakani
KRKole T. Roybal
Kole T. Roybal
Chimeric antigen receptors (CARs) repurpose natural signaling components to retarget T cells to refractory cancers but have shown limited efficacy in persistent, recurrent malignancies. Here, we introduce “CAR Pooling,” a multiplexed approach to rapidly identify CAR designs with clinical potential. Forty CARs with signaling domains derived from a range of immune cell lineages were evaluated in pooled assays for their ability to stimulate critical T cell effector functions during repetitive stimulation that mimics long-term tumor antigen exposure. Several domains were identified from the tumor necrosis factor (TNF) receptor family that have been primarily associated with B cells. CD40 enhanced proliferation, whereas B cell–activating factor receptor (BAFF-R) and transmembrane activator and CAML interactor (TACI) promoted cytotoxicity. These functions were enhanced relative to clinical benchmarks after prolonged antigen stimulation, and CAR T cell signaling through these domains fell into distinct states of memory, cytotoxicity, and metabolism. BAFF-R CAR T cells were enriched for a highly cytotoxic transcriptional signature previously associated with positive clinical outcomes. We also observed that replacing the 4-1BB intracellular signaling domain with the BAFF-R signaling domain in a clinically validated B cell maturation antigen (BCMA)–specific CAR resulted in enhanced activity in a xenotransplant model of multiple myeloma. Together, these results show that CAR Pooling is a general approach for rapid exploration of CAR architecture and activity to improve the efficacy of CAR T cell therapies.

31 August 2020 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
CTCorey Tan
Corey Tan
RHRyosuke Hiwa
Ryosuke Hiwa
JMJames L. Mueller
James L. Mueller
VVVivasvan Vykunta
Vivasvan Vykunta
KHKenta Hibiya
Kenta Hibiya
JZJulie Zikherman
Julie Zikherman

31 August 2023 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
JBJeremy F. Brooks
Jeremy F. Brooks
JRJulianne Riggs
Julianne Riggs
JMJames L. Mueller
James L. Mueller
RMRaisa Mathenge
Raisa Mathenge
WWWei-Yun Wholey
Wei-Yun Wholey
JZJulie Zikherman
Julie Zikherman

15 July 2019 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
MNMark Noviski
Mark Noviski
CTCorey Tan
Corey Tan
JHJohn Huizar
John Huizar
VVVivasvan Vykunta
Vivasvan Vykunta
JMJames L. Mueller
James L. Mueller
JZJulie Zikherman
Julie Zikherman
It has long been appreciated that highly autoreactive BCRs are actively removed from the developing B cell repertoire by Ag-dependent receptor editing and deletion. However, there is persistent debate about whether mild autoreactivity is simply tolerated or positively selected into the mature B cell repertoire as well as at what stage, to what extent, under what conditions, and into which compartments this occurs. In this study, we describe two minor, trackable populations of B cells in B1-8i Ig transgenic mice that express the VH186.2 H chain and recognize a common foreign Ag (the hapten 4-hydroxy-3-nitrophenylacetyl) but differ in L chain expression. We use the Nur77-eGFP reporter of BCR signaling to define their reactivity toward endogenous Ags. The less autoreactive of these two populations is strongly counterselected during the development of mature B1a, follicular, and marginal zone B cells. By genetically manipulating the strength of BCR signal transduction via the titration of surface CD45 expression, we demonstrate that this B cell population is not negatively selected but instead displays characteristics of impaired positive selection. We demonstrate that mild self-reactivity improves the developmental fitness of B cell clones in the context of a diverse population of B cells, and positive selection by endogenous Ags shapes the mature B cell repertoire.